Question 1

Does Engineers Gate Manager own PTGX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Engineers Gate Manager holds 4,373 shares of PTGX (Protagonist Therapeutics), worth $536,042.

Question 2

How many shares of PTGX does Engineers Gate Manager own?

Accepted Answer

As of its Q2 2026 13F, Engineers Gate Manager holds 4,373 shares of PTGX (Protagonist Therapeutics).

Question 3

What is Engineers Gate Manager's PTGX position worth?

Accepted Answer

As of its Q2 2026 13F, Engineers Gate Manager's PTGX position is worth $536,042.

Question 4

Is Engineers Gate Manager buying or selling PTGX?

Accepted Answer

In Q2 2026, Engineers Gate Manager opened a new PTGX position of 4,373 shares.

Question 5

When did Engineers Gate Manager first buy PTGX?

Accepted Answer

Engineers Gate Manager first reported PTGX in its Q4 2020 13F and has listed it in 12 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	4,373	—	$536,042	0.0%	$122.58	34
2025-Q2	Exited	0	-100.0%	$0	0.0%	$55.27	0
2025-Q1	New	15,327	—	$741,214	0.0%	$48.36	34
2024-Q3	Exited	0	-100.0%	$0	0.0%	$45.00	0